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http://www.jbioleng.org/content/7/1/29RESEARCH Open AccessThe Bacillus BioBrick Box: generation and
evaluation of essential genetic building blocks
for standardized work with Bacillus subtilis
Jara Radeck1†, Korinna Kraft1†, Julia Bartels1, Tamara Cikovic1, Franziska Dürr1, Jennifer Emenegger1,
Simon Kelterborn1, Christopher Sauer1,3, Georg Fritz1,2, Susanne Gebhard1 and Thorsten Mascher1*Abstract
Background: Standardized and well-characterized genetic building blocks are a prerequisite for the convenient and
reproducible assembly of novel genetic modules and devices. While numerous standardized parts exist for Escherichia
coli, such tools are still missing for the Gram-positive model organism Bacillus subtilis. The goal of this study was to
develop and thoroughly evaluate such a genetic toolbox.
Results: We developed five BioBrick-compatible integrative B. subtilis vectors by deleting unnecessary parts and
removing forbidden restriction sites to allow cloning in BioBrick (RFC10) standard. Three empty backbone vectors
with compatible resistance markers and integration sites were generated, allowing the stable chromosomal integration
and combination of up to three different devices in one strain. In addition, two integrative reporter vectors,
based on the lacZ and luxABCDE cassettes, were BioBrick-adjusted, to enable β-galactosidase and luciferase
reporter assays, respectively. Four constitutive and two inducible promoters were thoroughly characterized by
quantitative, time-resolved measurements. Together, these promoters cover a range of more than three orders
of magnitude in promoter strength, thereby allowing a fine-tuned adjustment of cellular protein amounts.
Finally, the Bacillus BioBrick Box also provides five widely used epitope tags (FLAG, His10, cMyc, HA, StrepII),
which can be translationally fused N- or C-terminally to any protein of choice.
Conclusion: Our genetic toolbox contains three compatible empty integration vectors, two reporter vectors
and a set of six promoters, two of them inducible. Furthermore, five different epitope tags offer convenient
protein handling and detection. All parts adhere to the BioBrick standard and hence enable standardized work
with B. subtilis. We believe that our well-documented and carefully evaluated Bacillus BioBrick Box represents a
very useful genetic tool kit, not only for the iGEM competition but any other BioBrick-based project in B. subtilis.
Keywords: Bacillus subtilis, BioBrick standard, iGEM, lux, Luminescence, Epitope tag, Integrative vector, Plasmid,
Inducible promoterIntroduction
One core aspect of synthetic biology projects that sets them
apart from “classical” genetic work is the application of
engineering principles such as abstraction, modularity and
standardization to assembly strategies and procedures.
The characterization and standardization of reusable genetic* Correspondence: mascher@bio.lmu.de
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reproduction in any medium, provided the orbuilding blocks is one of the prerequisites for the engin-
eering approach of building complex synthetic biological
systems [1]. Towards that end, the Registry of Standard
Biological Parts (partsregistry, [2]) was founded by the
Massachusetts Institute of Technology in 2003 as a
repository for the international Genetically Engineered
Machine competition (iGEM) and now maintains and
distributes over ten thousand standardized biological
parts that adhere to the BioBrick standard as described
in the “request for comments 10” (RFC 10) [3]. Such
standardized genetic parts – which have for exampleLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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genetic circuitries, such as a bacterial camera or a push-
on-push-off-switch [4,5] – not only significantly simplify
devices assembly, but also increase the reproducibility of
the resulting constructs [6].
While there are a number of other assembly techniques
like Gibson assembly [7], Golden Gate shuffling [8,9]
or MoClo [10], the BioBrick standard still plays a key
role in the framework of the annual iGEM competition.
Moreover, it is also very useful for any other lab, since it is
based on standard type II restriction endonucleases used
for routine cloning. While the use of such standardized
parts and assembly strategies is organism-independent,
there is nevertheless a need for specific parts that
accommodate organism-specific requirements, such as
G+C content, codon preference and different expres-
sion and/or regulatory signals.
The classical BioBrick standard allows the free combin-
ation of most parts, but does not work for translational
fusions, e.g. for addition of gfp or epitope-tags to protein-
coding sequences. For this purpose, a number of BioBrick-
compatible adaptations were developed, as described in
RFC 23 and RFC 25 [11,12]. In each case, the combination
of parts is performed via standard restriction digests and
subsequent ligations, preferably with vector backbones
of different antibiotic resistances to allow the so-called
3A-assembly [13].
Currently, the vast majority of available parts in the
Registry of Standard Biological Parts were designed for
the Gram-negative model organism Escherichia coli, due
to its central role in iGEM and other synthetic biology
projects. For other organisms, such as the Gram-positive
model organism Bacillus subtilis, the range of available
BioBricks is still very limited, especially when looking
for well-evaluated and reliable parts. This limitation is
unfortunate, given the unique features, powerful genetics
and biotechnological relevance of this bacterium.
B. subtilis, together with other Bacillus species, is one
of the main producers of industrially relevant enzymes,
such as proteases, amylases and lipases. Its excellent
fermentation properties, the ability to efficiently secrete
proteins and the lack of toxic by-products render it indis-
pensable for the biotechnological industry [14]. B. subtilis
is the by far best-characterized Gram-positive bacterium
[15], due to its powerful genetics and advantages for
industrial use. In addition, B. subtilis has also become
a model organism for studying bacterial (multicellular)
differentiation, because of its capability to form highly
resistant endospores upon nutrient limitation [16-18].
Another transient differentiation strategy is to become
naturally competent for genetic transformation by synthe-
sizing the machinery necessary for DNA uptake [17,19,20].
The high efficiency of this process and its tight association
with homologous recombination not only enables easygenetic manipulations of the chromosome, but has also
led to the development of mostly integrative vectors for
use in B. subtilis, even though replicative vectors can also
be used [21]. The advantages of integrative vectors are
their stable maintenance and hence also defined copy
number inside the chromosome.
Based on all those features and differences, the 2012
LMU-Munich iGEM-team decided to develop and provide
a set of essential genetic tools for the work with B. subtilis.
First of all, empty compatible integrative vectors are
needed that can carry any construct of choice. Second,
well-evaluated promoters of different strength, both
constitutive and inducible, are required to control gene
expression levels. For their evaluation and as a tool for
measuring the activity of other promoters, reporter
vectors are also required. For that purpose, we chose the
well-established lacZ reporter, encoding the β-galactosidase,
as well as a luciferase reporter (luxABCDE), which we
carefully evaluated for the first time. Moreover, a set of
epitope tags is provided to enable the convenient detection
and purification of proteins. The resulting toolbox presented
here, called the Bacillus BioBrick Box, (Table 1) is now
completely evaluated and freely available in two DNA
repositories, the Registry of Standard Biological Parts [2]
and the Bacillus Genetics Stock Center [22]. The vector
sources and formatted GeneBank files are given in Table 2
and Additional file 1, respectively.
Results and discussion
The vectors of the Bacillus BioBrick Box
To allow the integration of new devices and modules
into the chromosome of B. subtilis, we first constructed
five vectors (see Table 1 and Figure 1) by modifying
established B. subtilis vectors to comply with the BioBrick
standard. As described in detail below, we chose the
original B. subtilis vectors such that they harbor three
different resistance cassettes and also compatible homology
regions for integration into the B. subtilis chromosome.
This way, all three vectors and derived plasmids can be
combined in a single strain. For convenient cloning, they
all contain the bla cassette for ampicillin resistance and an
E. coli origin of replication (ori).
The original B. subtilis vectors pDG1662, pAX01,
pDG1731 [23,24] were modified to generate “empty” vectors
that lack promoters and reporter genes (Figure 1A). Their
integrative part contains the flanking homology regions,
a resistance cassette for selection in B. subtilis and the
multiple cloning site (MCS), containing an rfp-cassette
flanked by the restriction sites EcoRI, NotI, XbaI (upstream)
and SpeI, NotI and PstI (downstream) (Figure 1C). They
allow cloning in BioBrick standard [3] with selection for
white colonies as a result of the removal of the rfp-insert,
which – if still present – leads to formation of red colonies
in E. coli. All unnecessary parts, such as promoters or
Table 1 Overview of the Bacillus BioBrick Box including a summary of the features
BioBrick Description and commentsa Reference of source BGSC # Registry #
Vectors
pBS1C Empty vector, integration at amyE, ampr, cmr pDG1662-derivative [23] ECE257 BBa_K823023
pBS2E Empty vector, integration at lacA, ampr, mlsr pAX01-derivative [24] ECE258 BBa_K823027
pBS4S Empty vector, integration at thrC, ampr, specr pDG1731-derivative [23] ECE259 BBa_K823022
pBS1ClacZ lacZ-reporter vector, integration at amyE, ampr, cmr pAC6-derivative [25] ECE260 BBa_K823021
pBS3Clux lux-reporter vector, integration at sacA, ampr, cmr pAH328-derivative [26] ECE261 BBa_K823025
Promoters
Pveg Very strong constitutive promoter [27] ECE262 BBa_K823003
PliaG Constitutive promoter [28] ECE263 BBa_K823000
PlepA Strong constitutive promoter [29] ECE264 BBa_K823002
J23101 Very weak constitutive promoter BBa_J23101 ECE266 BBa_K823005
PliaI Bacitracin-inducible promoter [30,31] ECE267 BBa_K823001
PxylA Xylose-inducible promoter [32] ECE268 BBa_K823015
Epitope-tags
His10 10xHis-tag [33] ECE269 BBa_K823037
FLAG FLAG-tag [34] ECE270 BBa_K823034
StrepII Streptactin-tag [35,36] ECE271 BBa_K823038
HA HA-tag [34,37] ECE272 BBa_K823035
cMyc cMyc-tag [34,38] ECE273 BBa_K823036
aampr, ampicillin resistance; cmr, chloramphenicol resistance; kanr, kanamycin resistance; spcr, spectinomycin resistance; mlsr, erythromycin-induced resistance to
macrolide, lincosamide and streptogramin B-antibiotics (MLS).
Radeck et al. Journal of Biological Engineering 2013, 7:29 Page 3 of 16
http://www.jbioleng.org/content/7/1/29additional resistance genes were deleted (see methods
for details on construction). In all vectors the restriction
sites interfering with the RFC 10 standard were removed.
Moreover, for the empty vectors we also removed all
AgeI and NgoMIV sites, thus allowing direct cloning in
“Freiburg” standard [11] for translational fusions. Align-
ments with original vectors are provided in Additional file 2.
The three empty vectors, designated pBS1C, pBS2E and
pBS4S, integrate into the amyE, lacA and thrC locus and
harbor cat, erm and spc resistance cassettes, respectively
(Table 1). The reporter vector pBS1ClacZ was derived
from pAC6 [25] and contains the β-galactosidase reporterTable 2 Vector sources for the Bacillus BioBrick Box
Vector Descriptiona
pAC6 Vector for transcriptional promoter fusions to lacZ; integr
pAH328 Vector for transcriptional promoter fusions to luxABCDE (l
pDG1662 Empty vector, integrates at amyE, cmr, spcr, ampr
pDG1731 Empty vector; integrates at thrC, spcr, mlsr, ampr
pAX01 Vector for xylose-dependent gene expression; integrates
pXT Vector for xylose-inducible gene expression; integrates in
pSB1C3 Replicative E. coli vector, MCS features rfp-cassette; cmr
pGFPamy Vector for transcriptional promoter fusions to gfpmut1; in
acmr, chloramphenicol resistance; kanr, kanamycin resistance; spcr, spectinomycin re
streptogramin B-antibiotics (MLS); MCS, multiple cloning site.gene lacZ from E. coli with the sacB ribosome binding
site (RBS) from B. subtilis downstream of the MCS. The
luciferase-reporter vector pBS3Clux, which was derived
from pAH328 [26], contains the luxABCDE-operon from
Photorabdus luminescence with all RBSs adjusted for use
in B. subtilis (Figure 1B). Both reporter vectors allow the
measurement of promoter activities based on transcriptional
fusions and mediate chloramphenicol resistance. They
integrate into the amyE (pBS1ClacZ) and sacA (pBS3Clux)
loci, respectively.
For transformation of B. subtilis, the vectors and derived
plasmids need to be linearized at a unique ScaI site insideUsed for Ref.
ates at amyE; cmr, ampr pBS1ClacZ [25]
uciferase); integrates at sacA; cmr, ampr pBS3Clux [26]
pBS1C [23]
pBS4S [23]
at lacA, mlsr, ampr pBS2E [24]
thrC; spcr, ampr PxylA [39]
MCS [40]
tegrates at amyE; cmr, ampr gfpmut1 [41]
sistance; mlsr, erythromycin-induced resistance to macrolid-, lincosamid- and
Figure 1 Maps of the modified Bacillus BioBrick Box-vectors in BioBrick (RFC10) standard. Resistance genes are indicated in green, reporter
genes in orange and the origin of replication for E. coli as well as the integration loci are shown as gray boxes. The integrative part of the
vectors is marked with a thin black line inside each vector map. The vector names are based on the following nomenclature: p = plasmid,
BS = B. subtilis; the number refers to the integration locus: 1 = amyE, 2 = lacA, 3 = sacA, 4 = thrC; and the last letter codes for the resistance in
B. subtilis: C = chloramphenicol (mediated by cat), E = MLS (mediated by erm: specifies resistance to macrolide, lincosamide and
streptogramin B antibiotics if induced by erythromycin), S = spectinomycin (mediated by spc)). The addition in italics refers to the functional
part of the reporter vectors: lacZ for β-galactosidase and lux for the luxABCDE-cassette encoding luciferase. (A) The three empty integrative
vectors pBS1C, pBS2E and pBS4S contain different resistance genes (cat, erm, spec) and integration loci (amyE, lacA, thrC). This compatibility
allows a combined usage in one single strain. They are derived from pDG1662, pAX01 and pDG1731, respectively. (B) Reporter vectors
encoding β-galactosidase (lacZ) or luciferase (luxABDCE) as reporter genes. They integrate into amyE or sacA, respectively, and both mediate
chloramphenicol resistance. All vectors harbor the RFC10-compatible multiple cloning site with an rfp-cassette, as shown in (C). See text
and material and methods for details on construction.
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a second ScaI site within the integrative part. For this
vector, BsaI or PciI can be used for linearization. The
functionality of all empty vectors has been verified in a
number of different projects (own unpublished results).
The reporter vectors were subsequently used to evaluate
the different promoters of the Bacillus BioBrick Box
(see further below).
Characterization of the thrC integration locus
The four integration sites chosen for the vectors of
the Bacillus subtilis BioBrick Box are commonly used
for insertion of genetic constructs into the B. subtilischromosome. The sacA, lacA and amyE genes encode
metabolic enzymes required for the degradation of
different alternative carbohydrates, i.e. sucrose, galactans
and starch, respectively [42-44]. Accordingly, their expres-
sion is regulated by sugar availability [42,43,45], which is
easy to control by experimental design. The fourth locus,
thrC, is required for synthesis of threonine and amino
acids derived from it. Expression of the hom-thrC-thrB
operon was found to be high under many of the experi-
mental conditions tested in a recent expression profiling
study of B. subtilis [46]. While this is not surprising for an
amino acid biosynthesis operon, it has major implications
for use as an integration site. Regulation of the operon’s
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we therefore constructed a transcriptional Phom-luxABCDE
fusion to study the promoter activity under different growth
conditions.
During growth in LB medium, representing amino
acid-replete conditions, expression of Phom-luxABCDE
was at an intermediate level, reaching a maximum of
105 RLU/OD (Additional file 3: Figure S1). However, in the
defined CSE medium, promoter activities were strongly
increased and reached twelve times higher values than in
LB medium. Addition of 0.1% casamino acids reduced
these activities to two-fold above LB, and in the presence
of 1% casamino acids expression was similar to growth in
LB (Additional file 3: Figure S1). These data show that
some considerations are required when using thrC as an
integration site. That is, for applications in minimal or
defined media, any construct to be integrated into thrC
should contain a strong terminator upstream in order to
prevent undesired read-through from Phom.
The promoters of the Bacillus BioBrick Box
Promoters are crucial control elements for developing
complex in vivo expression programs. For this purpose,
they do not only have to be standardized, but also have
to show a predictable and reliable activity under a variety
of different conditions. For the optimization of metabolic
pathways, the fine-tuning of gene expression is indis-
pensable. Those features can sometimes be provided by
inducible promoters or by developing promoter libraries
[47-49], as described for E. coli [50,51]. To provide a
first set of characterized promoter-parts for B. subtilis, we
constructed and evaluated four constitutive promoters of
different strength, as well as two inducible promoters that
allow inducer-controlled gene expression levels.
Constitutive promoters
For our BioBrick Box, we chose three native σA-dependent
B. subtilis promoters and eleven representatives of the
Anderson promoter collection [51], which are often used
as a gold standard for constitutive gene expression in
E. coli. The native B. subtilis promoters comprise PliaG,
expressing regulatory components of the cell envelope
stress response system [28], PlepA, expressing highly con-
served genes in bacteria and mitochondria necessary for
exact protein translation [29], and Pveg, which is the stron-
gest constitutive promoter in B. subtilis known to date [27].
The latter controls transcription of the veg gene, which
seems to have an important function during the outgrowth
of spores [52].
All relevant sequence features of the promoters evaluated
in this study are shown in Figure 2; the complete sequences
of the cloned fragments can be found in Additional file 1.
To determine their activity in B. subtilis, the promoter
fragments were cloned into the luciferase reportervector pBS3Clux and assayed in LB medium as well as
in chemically defined MCSE medium (MOPS-based
CSE, see Methods for details).
Figure 3 shows both cell growth (Figure 3A/D) and
the resulting luciferase activities (Figure 3B/E) over an
extended growth period, ranging from exponential into
the stationary growth phase in the two growth media.
The activities, expressed as relative luminescence units
(RLU) per OD600, covered about three orders of magni-
tude (Figure 3B/E), ranging from ~103 RLU/OD for the
Anderson promoter J23101 to ~106 RLU/OD for the strong
Pveg promoter. For growth in LB, promoter activities varied
within a factor of two to three during exponential phase,
and declined during stationary phase by more than one
order of magnitude (Figure 3B). These variations likely arise
from metabolic changes that the cells undergo during
growth in this complex medium, as also reflected in the
ever-changing growth rate in LB medium (Figure 3A).
In contrast, the growth rate in the chemically defined
MCSE medium was more constant in exponential phase
(Figure 3D) and luciferase activities displayed less dynamic
variation than in LB medium (Figure 3E).
While the Anderson promoter J23101 is a strong pro-
moter in E. coli [51], deviating from the E. coli consensus
promoter sequence by only a single nucleotide exchange
in the −35 promoter region (TTGACA to TTTACA), it
was the only of eleven different Anderson promoters tested
in B. subtilis that generated a measurable luminescence
output at all (data not shown). Still, compared to the values
measured in E. coli, its activity was surprisingly low and
only about ten-fold above the background of the empty
vector (Figure 3B/E). This result clearly demonstrates
the context-dependence of expression signals and hence
stresses the importance of establishing organism-specific
parts.
The absolute luciferase activities as documented in
Figure 3B/E do not only depend on the promoter strength,
but are also dependent on experimental conditions and
setups, which can vary significantly between labs and
experiments. However, while absolute values might vary,
the relative strength of the promoters has proven to be a
rather robust and comparable unit between several experi-
ments and even between different research groups [54].
Towards that end, a suitable standard promoter, measured
under the same experimental conditions as the promoter
under consideration, serves as reference value, and pro-
moter activities are expressed relative to this standard pro-
moter as relative promoter units (RPUs) [54]. The stable
expression behavior and intermediate strength of PliaG
makes it ideally suited as a reference promoter, and hence
we propose to use PliaG for calculating RPUs in B. subtilis.
The RPUs for all constitutive promoters, calculated by
dividing their activity at an OD600 of 0.1 by the activity of
PliaG are shown in Figure 3C/F.
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Figure 3 Luciferase activities of the constitutive Bacillus BioBrick Box promoters. Measurement of promoter activity was done based on
pBS3Clux-derivatives via luminescence of 100 μl cultures growing in a plate reader (Biotek®, Synergy™2; 96-well plate, 37°C, shaking) over time.
The graphs are aligned to an OD600 = 0.1 at time point 0 (grey line). (A)-(C) show data of growth in complex LB medium; (D)-(F) show data of
growth in the defined medium MCSE. (A) and (D) Growth curves (OD600) from cultures of the reporter strains TMB1872 (lux without promoter),
TMB1862 (J23101-lux), TMB1856 (PliaG-lux), TMB1860 (PlepA-lux) and TMB1930 (Pveg-lux). (B) and (E) Promoter activities of the same strains expressed
as luminescence in relative luminescence units (RLU) per OD600 and using the same color code as in panels (A) and (D). (C) and (F) Bar graphs of
relative promoter units (RPUs, normalized to PliaG) at time point 0, corresponding to OD600 = 0.1. All graphs show mean values and standard
deviations (error bars) of at least four biological replicates.
Figure 2 Nucleotide sequences of the Bacillus BioBrick Box promoter collection. Sequences are aligned according to their −35 and −10
region. All promoter fragments were designed with 3′-end exactly upstream of the RBS. The −10 and −35 regions (if conserved) are shown in
bold and underlined. Regulator binding sites for XylR in PxylA and LiaR in PliaI are shown in italics and underlined. The native PxylA also contains a
catabolite responsive element (CRE) that suppresses the transcription in the presence of glucose [53]. This binding site is downstream of the
promoter and is not present in the PxylA –fragment used here, which is derived from the pXT vector [39].
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Next, we chose the bacitracin-inducible promoter PliaI for
our BioBrick Box, due to its high dynamic range and
low basal activity [30,31]. PliaI controls the liaIH operon
of B. subtilis, which is the main target of the envelope
stress-inducible two-component system LiaRS. Upon
induction with the cell wall antibiotic bacitracin, LiaS
activates the cognate response regulator LiaR, which in
turn strongly induces PliaI [28,55].
For quantitative analysis, PliaI was cloned into the
luciferase reporter vector pBS3Clux, grown to exponential
phase and induced with different concentrations of
bacitracin (see Methods for details). Both in LB as well as
in MCSE medium we observed a transient, concentration-
dependent increase of luciferase activities for about two
to four hours post-induction, which decreased about
100-fold towards stationary phase (Figure 4B/E). The
maximal activity of about 300-fold induction was reached
1 hour after bacitracin treatment in LB (30 minutes
in MCSE) at a concentration of 30 μg ml-1 bacitracin
(Figure 4C/F), as shown previously [31]. Furthermore,
induction with 30 μg ml-1 bacitracin leads to minor growth
defects, while higher bacitracin concentrations resulted
in the lysis of the culture (Figure 4A/D). The respective
dose-response curves expressed in RPUs (normalized to
PliaG) indicate that PliaI responded more sensitively to
low bacitracin concentrations in LB compared to MCSE
medium (Figure 4C/F). This might reflect higher stress
levels experienced due to faster growth in LB compared to
MCSE medium (Figure 4A/D). Notably, the basal activity
of PliaI was approximately 0.03 RPU and hence – in the
absence of a suitable inducer – perfectly fits into the
“activity gap” between the constitutive promoters J23101
(0.006 RPU) and PliaG (1 RPU).
The xylose-inducible promoter PxylA
Natively, PxylA drives the expression of the xylAB operon
in B. subtilis, which is required for using xylose as carbon
and energy source. This promoter is regulated by XylR
and CcpA and hence only induced by xylose if glucose is
simultaneously absent, due to carbon catabolite repression
[53]. The PxylA derivative used in this study is amplified
from the expression vector pXT [39] and lacks the
catabolite-responsive element (CRE). As a result, the
xylose-inducible promoter of the BioBrick Box is not
subject to repression. Nevertheless, the choice of carbon
source can still affect the xylose-dependent induction of
PxylA as described in more detail below.
The PxylA reporter responded to xylose in a concentra-
tion-dependent manner in both LB and MCSE medium
and reached its maximum activity about 1-1.5 hours
post-induction (Figure 5B/E). Due to a significantly in-
creased basal promoter activity in LB, there was only a
ten-fold difference between minimal and maximal activity(Figure 5C), compared to a 100-fold difference in MCSE
(Figure 5F). While the maximal activity of PxylA was
similar to PliaI, the basal activity of the non-induced
promoter, especially in LB medium, was significantly
higher for PxylA, resulting in a lower dynamic range. On
the other hand, the activity of PxylA was sustained, instead
of transient for PliaI, and the sensitivities towards its in-
ducer xylose were comparable in LB and MCSE medium
(Figure 5C/F).
As mentioned above, removal of the CRE sequence
from PxylA removed the repressive effects of glucose via
CcpA, but we still observed significantly reduced promoter
activities during growth on glucose as carbon source. It
was previously shown that glucose-6-phosphate competes
with xylose for binding to the xylose repressor protein
XylR and prevents its de-activation [56]. We therefore
tested xylose-dependent induction of PxylA during growth
in CSE medium containing different carbon sources.
During growth on glucose, addition of 0.2% xylose led
to a 20-fold promoter induction, while up to 70-fold
changes were observed during growth on fructose, manni-
tol or arabinose (Additional file 3: Figure S4). Metabolism
of the latter three sugars does not produce glucose-6-
phosphate as an intermediate and thus bypasses its repres-
sive effect. The reporter strain showed similar growth rates
during growth on glucose, fructose or mannitol (doubling
time ca. 50 min), while growth on arabinose was markedly
slower at ca. 65 min doubling times (Additional file 3:
Figure S4 and data not shown). Based on these results
we suggest using fructose as the carbon source for routine
experiments in minimal or defined media when working
with PxylA.
The reporters of the Bacillus BioBrick Box
Reporter genes are important genetic tools for the meas-
urement of promoter activities. The BioBrick Box therefore
provides the established lacZ [57] and the luxABCDE re-
porter in the aforementioned reporter vectors pBS1ClacZ
and pBS3Clux. To evaluate both vectors, we used the
bacitracin-inducible liaI promoter to compare the charac-
teristics of both reporters. The Miller units obtained for
the lacZ reporter were compared to the RLU/OD600 values
of the luxABCDE reporter one hour post-induction at
identical inducer concentrations.
Both reporters showed a high dynamic range over about
four orders of magnitude between the empty vector as
background and the maximal PliaI activity (Additional
file 3: Figure S2). Importantly, we observed a linear correl-
ation between PliaI-lux and PliaI-lacZ activity, demonstrating
that each of the reporters provides an accurate measure-
ment of promoter activity. Nevertheless, the lux-reporter
has several advantages over lacZ: luminescence can be
monitored online in growing cultures and neither requires
the addition of a substrate nor performing a separate
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http://www.jbioleng.org/content/7/1/29assay. Moreover, we have determined an average half-life
of only 4.2 ± 0.3 min for the luciferase signal (Additional
file 3: Figure S3), compared to a lifetime in the order of
hours for β-galactosidase (data not shown). Hence, the
lux reporter is particularly very well suited to resolve
transcriptional responses occurring at timescales shorter
than the cell-cycle. In fact, given this short lifetime one
might expect that the luminescence activity follows the
promoter activity almost instantly.
In order to test how closely the luminescence may follow
the underlying promoter activity, we devised a simplified
mathematical model that includes the processes of lux
mRNA transcription and degradation as well as Lux
protein translation and decay (Figure 6A); see Methodsfor all assumptions and details. This model then enabled
us to relate the time-dependent luminescence signal back
to the time-dependent changes in the apparent promoter
activity, by making the simplifying assumption that all
changes in the luminescence signal are caused by changes
in the transcription rate alone. As a proof-of-principle, we
fitted the experimental luminescence activity of the PliaI
promoter induced with 30 μg/ml bacitracin in MCSE
(Figure 6B; symbols) by our model (Figure 6B; colored
lines), and extracted the underlying time-dependent
apparent promoter activity (Figure 6C). Here it is clearly
visible that the fit of the experimental data is best for an
mRNA half-life of 5 min or shorter, since otherwise rapid
changes in the luminescence signal cannot be reproduced
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shows that the time course of the apparent promoter
activity is almost identical to the luminescence activity,
with only a ~10 min delay between promoter activity and
the luminescence signal (Figure 6C), further underlining
the power of the lux reporter in resolving highly dynamic
transcriptional responses. It should be noted that the large
fluctuations in apparent promoter activities at values below
10-2 arbitrary units are likely due to experimental noise and
do not necessarily reflect true changes in transcription rate.
The epitope tags of the Bacillus BioBrick Box
Epitope tags are useful tools for both protein detection by
Western blot analysis using tag-specific antibodies and forpurification purposes or protein interaction studies. In our
Bacillus BioBrick Box, we provide five widely used tags –
FLAG-, His10-, StrepII-, HA-, and cMyc-tag – in a modified
Freiburg standard that was developed to allow the gen-
eration of both N- and C-terminal translational fusions
(Figure 7A). The DNA and protein sequences of all tags
are shown in Figure 7B. To evaluate our tags, fusions to
gfpmut1 under control of a constitutive promoter were
generated as described in Methods. Western blot analyses
with GFP-specific antibodies showed that all proteins
could be detected in the soluble protein fraction and
were therefore correctly produced (Figure 7C). Analyses
with tag-specific antibodies showed that addition of the dif-
ferent tags led to a slight shifting of apparent sizes between
Figure 6 Inference of promoter activity from luminescence
measurements. (A) Quantitative mathematical model used to infer
the underlying promoter activity from luminescence time-series.
Here, the promoter activity is reflected in a time-dependent tran-
scription rate, α(t). luxABCDE mRNA is degraded at rate log(2)/τm ,
translated at rate β into Lux proteins, which are in turn degraded at
rate log(2)/τp. For simplicity, the model assumes a single Lux protein
species, which is rate-limiting for luciferase activity and considered to
be directly proportional to luminescence output. (B) As a test case for
our method, the luciferase activity of pBS3Clux-PliaI (TMB1858) induced
with 30 μg/ml bacitracin (symbols) was fitted by our quantitative math-
ematical model (solid lines). Since the luxABCDE mRNA half-life is un-
known in B. subtilis, we fitted the data using a physiological spectrum
of half-lives (τm = 3, 5 and 10 min) and found that the model can re-
produce the highly dynamic luciferase activity (arrow) only for mRNA
half-lives of 5 min and shorter. (C) Underlying apparent promoter activ-
ity in arbitrary units (au) for the fits in (B). For all details see main text.
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on the SDS-PAGE (Figure 7C).
The original FLAG-tag was developed as hydrophilic
hexapeptide marker sequence (Lys-Asp-Asp-Asp-Asp-Lys)
that is located at the outside of protein surfaces. Adapta-
tion to B. subtilis was performed by Kaltwasser et al. [34].In Western blots, the C-terminal fusion to GFP can be de-
tected very well, while the signal for the N-terminal fusion
was weak. The His10-tag was developed and is used for
affinity purification on Ni2+-NTA-columns and Western
blotting [33]. Both the N- and C-terminal fusions to GFP
were easily detectable in Western blots (Figure 7C).
The Strep-tag II, which was optimized from the original
Strep-tag to allow both N- and C-terminal fusion, can be
used together with the streptavidin-derivative Strep-Tactin
as its specific binding partner [35,36]. The expression of
the N-terminal fusion seemed to be rather low (anti-GFP
blot) and detection with anti-strep antibodies was weak.
Nevertheless, Strep-tagII is the epitope of choice for
co-immunoprecipitation in protein-protein interaction
studies in B. subtilis due to the highly specific interaction
with Strep-Tactin-covered magnetic beads or resins [58].
The HA-tag was named after the human influenza
hemagglutinin, a viral surface protein that is important
for host cell infection [37]. The corresponding HA-tag
was codon-optimized for B. subtilis [34] and worked very
well for detection of C-terminally tagged GFP. The cMyc-
tag is derived from the human c-myc proto-oncogene [38],
which was also optimized for B. subtilis [34]. C-terminal
fusion to gfp seemed to negatively influence the GFP-
expression levels. However, the detection with anti-cMyc-
antibodies worked well for both N- and C-terminal fusions.
In summary, all five epitope tags were shown to be
functional. The ideal terminus for creating protein-tag
fusions as well as the most suitable tag will have to be
determined experimentally for each target protein and
application. For such studies, the parts from the BioBrick
Box offer a convenient and fast way for optimization of
conditions and constructs.
Conclusion
In this study, we described the construction and evaluation
of a toolkit containing essential vectors, promoters and
epitope-tags for standardized genetic assembly in B. subtilis,
a biotechnological workhorse and Gram-positive model
organism.
We modified and adapted five integrative B. subtilis
vectors to the BioBrick standard. Three are empty vectors
that are fully compatible to each other and allow their
combination in one single strain due to different integration
loci and resistance cassettes. Two additional reporter
vectors harbor lacZ and luxABCDE cassettes for evaluating
transcriptional promoter fusions. While β-galactosidase is
already long established as a reporter and needs no further
introduction, we conducted a detailed study of the lux-
reporter system. We determined the half-life of the luci-
ferase signal as 4.2 ± 0.3 min, making the reporter instable
enough to directly monitor both induction and repression
of promoters almost in real time, as revealed by our
mathematical model for the lux-reporter system. This
AB
RFC10: GAATTCGCGGCCGCTTCTAGAG ATG.......part...........TACTAGTAGCGGCCGCTGCAG 
RFC25: GAATTCGCGGCCGCTTCTAGA TGGCCGGC..........part..ACCGGTTAATACTAGTAGCGGCCGCTGCAG 
RFC25M:  GAATTCGCGGCCGCTTCTAGAAAGGAGGTGTGTGTAATGGCCGGC.part..ACCGGTTAATACTAGTAGCGGCCGCTGCAG 
EcoRI NotI XbaI SpeI NotI PstIRBS NgoMIV AgeI
Anti-tag 
Tag-GFP GFP-tag
1 2 1 2
Anti-GFP
Tag-GFP GFP-tag 
1 2 1 2
C
Sequence (nucleotide/amino acid)Tag
GAC TAC AAA GAC GAT GAC GAC AAG 
Asp Tyr Lys Asp Asp Asp Asp Lys 
CAT CAT CAT CAT CAT CAT CAT CAT CAT CAT
His His His His His His His His His His
TGG AGC CAC CCG CAG TTC GAA AAA 
Trp Ser His Pro Gln Phe Glu Lys
TAT CCG TAT GAT GTT CCG GAT TAT GCA
Tyr Pro Tyr Asp Val Pro Asp Tyr Ala
GAA CAA AAA CTT ATT AGC GAA GAA GAT CTT
Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu
HA
cMyc
His10
StrepII
FLAG
Tag
HA
cMyc
His10
StrepII
FLAG
Figure 7 Epitope tags of the Bacillus BioBrick Box. (A) Pre- and suffixes of different cloning standards. The start- and the first stop-codon are
underlined. RFC10 [3] describes the commonly used BioBrick standard. To combine two parts, the upstream part is cut with SpeI, the downstream
one with XbaI (red sites). The compatible overhangs of the two isocaudomers can be ligated, and result in an eight basepair scar that cannot be
recut but is optimal for RBS spacing. This causes a frameshift that is not suitable for translational fusions. RFC25 [11] describes the “Freiburg
standard” which was developed by the 2007 iGEM-Team from Freiburg to allow translational fusions. Two parts can be combined similar to
RFC10, but using NgoMIV and AgeI as restriction enzymes. The resulting scar ACCGGC codes for Threonine and Glycine. RFC25M refers to our
modification of RFC25 by adding an optimized RBS (yellow). While this convenient modification simplifies the cloning procedure, it should be
noted that as a consequence it also prevents downward compatibility, since the resulting BioBrick directly adds two functional DNA parts in a
single step. The tag-BioBricks and gfpmut1 are designed in that standard. (B) Nucleotide and amino acid sequences of the epitope tags, without
the RFC25M pre- and suffixes shown in (A). (C) Western blots of N- and C-terminal fusions of each tag to GFP, using the strains TMB1920
(Flag-gfp), TMB1921 (gfp-Flag), TMB1922 (HA-gfp), TMB1923 (gfp-HA), TMB1924 (cMyc-gfp), TMB1925 (gfp-cMyc), TMB1926 (His-gfp), TMB1927
(gfp-His), TMB1928 (StrepII-gfp) and TMB1929 (gfp-StrepII). For each construct, two independent clones were tested with epitope tag- and
GFP-specific antibodies as a positive control.
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and the possibility to determine promoter activities directly
in growing cultures, makes this an ideal reporter system,
especially since the lux cassette from P. luminescence
present in pBS3Clux does not require the addition of any
luciferase substrate.
Four constitutive promoters and the uninduced PliaI offer
an activity range of three orders of magnitude with stable
expression levels in defined MCSE medium and during
exponential growth phase in LB medium. We adopted the
concept of RPUs for B. subtilis and propose the PliaG
promoter to be used as a reference standard for RPU deter-
mination in this organism. The Bacillus BioBick Box also
contains two inducible promoters, PliaI and PxylA, which were
thoroughly evaluated with the inducers bacitracin and xylose,
respectively. Using inducer concentrations over about three
orders of magnitude, the two promoters revealed a dynamic
range of 300- or 100-fold activity over background, respect-
ively. PliaI has a transient activity in complex and defined
medium, whereas PxylA displays sustained induction.Finally, we evaluated five widely used epitope tags as
N- and C-terminal fusions to GFP via Western blotting.
All are functional, but results for the test case GFP
indicate a context-dependence in immuno-detection:
The FLAG- and HA-tag were only suitable for C-terminal
fusions to GFP, whereas His10 and cMyc worked both for
N- and C-terminal fusions.
Taken together, we provide a set of well-evaluated
standardized tools for the work in B. subtilis. We hope
that this toolkit will inspire not only future iGEM-teams
to choose B. subtilis as their chassis organism, but also
greatly facilitate the engineering of this versatile model
organism for synthetic biology applications in the future.
Methods
Bacterial strains and growth conditions
B. subtilis and E. coli were routinely grown in Luria-Bertani
(LB) medium (1% (w/v) tryptone, 0.5% (w/v) yeast extract,
1% (w/v) NaCl) at 37°C with agitation (200 rpm). All strains
used in this study are listed in Additional file 3: Table S2.
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(10 μg ml-1), spectinomycin (100 μg ml-1), chloramphenicol
(5 μg ml-1), or erythromycin in combination with lin-
comycin (1 μg ml-1; 25 μg ml-1 for mlsr). Selective media
for E. coli contained ampicillin (100 μg ml-1) or chloram-
phenicol (35 μg ml-1). Solid media additionally contained
1.5% (w/v) agar.
Transformation
E. coli (XL1 blue, Stratagene) competent cells were
prepared and transformed according to OpenWetWare
[59]. Transformations of B. subtilis were carried out as
described previously [21]. The integration of plasmids
into the B. subtilis genome was checked on starch plates
(amyE), with minimal medium (thrC) or colony PCR (sacA,
lacA). Detailed protocols can be found in the Additional
file 3 and [60].
MOPS-based chemically defined medium with succinate
and glutamate (MCSE)
The chemically defined CSE medium (3.3 g l-1 (NH4)
2SO4, 29 mM KH2PO4, 70 mM K2HPO4, 1 × III’-salts
(100 × III’-salts: 0.232 g l-1 MnSO4 × 4 H2O, 12.3 g l
-1
MgSO4 × 7 H2O), 50 mg l
-1 Tryptophan, 22 mg l-1am-
monium ferric citrate, 0.8% (w/v) K-glutamate, 0.6%
(w/v) Na-succinate, up to 2.5% (w/v) C-source) is used for
experiments with stable growth conditions and a defined
C-source [61]. In long-term experiments (18 hours), we
noticed a white precipitate disturbing the OD600-measure-
ments in the microplate reader. We tested the use of a
phosphate-reduced 3-(N-Morpholino)-Propanesulfonic acid
(MOPS) buffer (10 ×MOPS buffer: 83.72 g l-1 MOPS,
33 g l-1 (NH4)2SO4, 3.85 mM KH2PO4, 6.15 mM K2HPO4;
adjusted to pH 7 with KOH), which did not cause precipi-
tation. This is the composition of the newly developed
MOPS-based MCSE medium: 1 ×MOPS, 50 mg l-1 Tryp-
tophan, 22 mg l-1ammonium ferric citrate, 1 × III’-salts,
0.8% (w/v) K-glutamate, 0.6% (w/v) Na-succinate, 0.2%
(w/v) fructose. The C-source for MCSE can be varied
according to the experimental requirements.
DNA manipulation and plasmid construction
General cloning procedure, such as endonuclease restric-
tion digest, ligation and PCR, was performed with enzymes
and buffers from New England Biolabs (NEB; Ipswich, MA,
USA) according to the respective protocols. For subsequent
cloning, Phusion® polymerase was used for PCR amplifica-
tions, otherwise OneTaq® was the polymerase of choice.
PCR-purification was performed with the HiYield PCR Gel
Extraction/PCR Clean-up Kit (Süd-Laborbedarf GmbH
(SLG), Gauting, Germany). Plasmid preparation for muta-
genesis-PCR templates was performed with the HiYield
Plasmid Mini-Kit (SLG) according to the manufacturer’s
protocol, otherwise by alkaline lysis plasmid preparation.All plasmids created during this study are listed in
Additional file 3: Table S1, all primer sequences are given
in Additional file 3: Table S3.
Vectors of the Bacillus BioBrick Box
In all vectors, the PstI site in the bla gene was removed
by site-directed mutagenesis using the oligonucleotides
TM2206 and TM2207. The resulting vector is marked with
the auxiliary “blamut”. Primer design and mutagenesis were
performed according to the manufacturer’s instructions for
the QuikChange® II Site-Directed Mutagenesis Kit (Agilent
Technologies). All plasmids were test-digested to confirm
removal of the restriction site.
To create the empty vector pBS1C, pDG1662blamut
was cut with PstI to remove one XbaI site and the spcr
outside of the integrative part. The 6 kb fragment was
religated. The remaining PstI site was mutated via site-
directed mutagenesis with the primers TM2845 and
TM2846. To insert the MCS, the vector was cut with
EcoRI. The MCS was amplified by PCR from pSB1C3
with the Primers TM2843 and TM2844, cut with EcoRI
and BsaI (EcoRI-compatible overhang) and ligated into the
vector. The remaining NgoMIV sites were removed by sub-
sequent site-directed mutagenesis with TM3005 +TM3006,
TM3011 +TM3012 and TM3013 +TM3014, respectively,
resulting in pBS1C.
To create the empty vector pBS2E, pAX01 was cut with
SacI. The 6.3 kb fragment was religated to remove the
xylR-PxylA-fragment. The PstI site in bla was removed.
The vector was cut with XbaI and the 6 kb fragment
religated to reduce the amount of forbidden restriction
sites. The lost terminator of erm was replaced by the
PCR-amplified terminator with BsaI-overhangs (primers:
TM2975 and TM2976). The vector was opened with XbaI
and ligated with the PCR product cut with BsaI (XbaI-
compatible overhang). The correct direction was checked
by sequencing and removal of the XbaI-site was confirmed.
Finally, the MCS was amplified from pSB1C3 (TM2608
and TM2609) with PstI and NsiI overhangs, cut with PstI
and NsiI and ligated into the PstI-cut vector. Correct
orientation of the insert was confirmed by restriction
digest and sequencing. The remaining NgoMIV sites were
removed by subsequent site-directed mutagenesis with
TM3011 + TM3012 and TM3028 + TM3029, respectively,
resulting in pBS2E.
To create the empty vector pBS4S, the erm-resistance
outside of the integrative part of pDG1731 was removed
via cut-ligation with MluI and BssHI, resulting in a 4.7 kb
vector. The PstI site in bla was removed as described above.
The PstI site in thrB was removed performing site-directed
mutagenesis with the primers TM2835 and TM2836. The
spc-promoter with upstream PstI-overhang was amplified
with the primers TM2837 and TM2838 and cut with PstI
and PciI. The MCS was cut from pSB1C3 with EcoRI and
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4.3 kb-fragment ligated with both cut DNA-fragments. The
remaining NgoMIV sites were removed by subsequent
site-directed mutagenesis with TM3005 + TM3006 and
TM3011 + TM3012, respectively, resulting in pBS4S.
To create the reporter vector pBS1ClacZ, pAC6blamut
was cut with EcoRI and PstI. The primers TM2301 and
TM2302 (1 pM) were mixed, heated (95°C, 10 min),
re-annealed (50°C, 10 min) to become double stranded
with 4 bp overhangs and ligated into the vector. The
vector was cut with EcoRI and PstI and ligated with
the MCS from pSB1C3 cut with EcoRI and PstI. A PstI
site in the E. coli ori was removed by cutting with BglII
and religation of the 11 kb fragment.
To create the reporter vector pBS3Clux, the PstI site
in the sacA locus of pAH328blamut was removed by
site-directed mutagenesis with the primers TM2885 and
TM2886. Then, the XbaI site of luxD was removed
similarly with the Primers TM2887 and TM2888. The
MCS was amplified by PCR from pSB1C3 with the
primers TM2843 and TM2884, cut with EcoRI and BsaI
(SpeI-overhang) and ligated into the EcoRI/SpeI-cut vector.Promoters of the Bacillus BioBrick Box
The promoter J23101 was used from the parts registry [2].
The promoters PliaG, PlepA, Pveg and PliaI were amplified
from B. subtilisW168 genomic DNA using the primer pairs
TM2891/TM2892, TM2899/TM2900, TM2903/TM2904
and TM2895/TM2896, respectively. PxylA was amplified
from pXT [39] with the primers TM2968 + TM2969. The
PCR products were cut with EcoRI and SpeI, ligated
into pSB1C3, pBS3Clux and pBS1ClacZ (PliaI only) and
verified by sequencing.Epitope-tags of the Bacillus BioBrick Box
All eptitope tags were synthesized with pre- and suffixes
(Figure 7A) together as a single part in a plasmid from
GeneArt (Life Technologies Corporation, USA). The plas-
mid was cut with EcoRI and PstI and, without purification
steps, ligated into pSB1C3 cut with EcoRI and PstI.
The products were checked by sequencing for their
correct insert. gfpmut1 was adapted to modified Freiburg
standard by PCR with the primers TM2934/TM2935 and
pGFPamy as template and cloned into pSB1C3 (both
cut with EcoRI and SpeI). For translational fusion, the
pSB1C3-tag-constructs were cut open with AgeI + PstI
(tag is N-terminal) or EcoRI +NgoMIV (tag is C-terminal)
and purified. gfp was cut with the corresponding restriction
enzymes of the Freiburg standard, purified from an agarose
gel and ligated into the vector. The tag-gfp or gfp-tag
fusions as well as pBS0KPspac* were cut with EcoRI
and PstI, purified from agarose gels, ligated and verified by
sequencing.Luciferase assay
Luciferase activities of strains harbouring pBS3Clux-
derivates were assayed using a Synergy™2 multi-mode
microplate reader from BioTek® (Winooski, VT, USA). The
reader was controlled using the software Gen5™. Culture
volumes were 100 μl per well in 96-well plates (black walls,
clear bottom; Greiner Bio-One, Frickenhausen, Germany),
and incubation occurred at 37°C with agitation (intensity:
medium). Cell growth was monitored by optical density at
600 nm wavelength (OD600). Raw luminescence output
(relative luminescence units, RLU) was normalized to cell
density by dividing each data-point by its corresponding
corrected OD600 value (RLU/OD).
For constitutive promoters, LB or MCSE medium was
inoculated 1:500 from overnight cultures of each strain.
Cultures were incubated at 37°C with agitation and
OD600 as well as luminescence were monitored every
10 min for at least 13 hours. For inducible promoters,
10 ml of LB or MCSE medium were inoculated 1:500
from overnight cultures and grown to OD600 = 0.2-0.5.
Those pre-cultures were diluted to OD600 = 0.05 (MCSE)
or 0.01 (LB), respectively, and transferred to eight (PliaI) or
ten (PxylA) wells of a 96-well plate. The OD600 as well as
luminescence were monitored every 10 min for one hour.
At an OD600 ~ 0.1 (corresponding to OD600 ~ 0.4 in
cuvettes of 1 cm light path length) 5 μl of the inducer was
added to final concentrations of 0.1, 0.3, 1, 3, 10, 30 or
100 μg ml-1 Zn2+-bacitracin or 0.001, 0.003, 0.005, 0.01,
0.02, 0.03, 0.07, 0.2, 0.5% (w/v) xylose. To one culture-well,
5 μl of water was added as uninduced control. Cultures
were incubated at 37°C with agitation and the OD600 as
well as luminescence were monitored every 10 min for at
least 13 hours.
β-Galactosidase assay
LB medium (30 ml) was inoculated 1:100 from fresh
overnight culture of strains harboring pBS1ClacZ-PliaI
or pBS1ClacZ without promoter and grown at 37°C,
shaking at 200 rpm. At OD600 = 0.4-0.6, the culture was
split into 3 ml samples and induced with 30 μl of
Zn2+-bacitracin to the final concentrations of 0.1, 0.3, 1,
3, 10, 30 or 100 μg ml-1. To one sample, 30 μl of water
was added as a negative control. After incubation for
another 30 min, 2 ml of the samples were harvested by
centrifugation (13000 × g, 1-3 min) and the pellets were
stored at −20°C. For the assay, the pellets were resuspended
in 1 ml of working buffer and assayed for β-galactosidase
activity as described elsewhere, with normalization to cell
density [62].
Western blot analysis
To verify the functionality of the epitope tags, Western
blot analyses of the strains TMB1920-TMB1929 were
performed. LB medium (15 ml) was inoculated 1:100
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OD600 ~ 0.5. Of this, 10 ml were harvested by centrifuga-
tion (8000 × g, 5 min) and the pellets stored at −20°C.
Pellets were resuspended in 1 ml disruption buffer
(50 mM Tris–HCl pH 7.5, 100 mM NaCl) and lysed by
sonication. Samples (12 μl of lysate) were loaded per
lane on two 12.5% SDS-polyacrylamide gels and SDS-
PAGE was performed according standard procedure
[60]. One gel was stained with colloidal coomassie, the
other one was used for protein transfer to a PVDF
membrane (Merck Millipore, Billerica, MA, USA) by
submerged blotting procedure (Mini Trans-Blot Elec-
trophoretic Transfer Cell (Bio-Rad, Hercules, CA,
USA)). After protein transfer, the membranes were
treated with the following antibodies and conditions.
Detailed protocols can be found in the Additional file 3.
GFP
Probing with primary antibodies takes place with rabbit
anti-GFP antibodies (1:3000, Epitomics, No. 1533). Horse-
radish-peroxidase (HRP)-conjugated anti-rabbit antibodies
(1:2000, Promega, W401B) were used as secondary
antibody. Hybridization of both antibodies was carried out
in Blotto-buffer (2.5% (w/v) skim milk powder, 1 × TBS
(50 mM Tris–HCl pH 7.6, 0.15 M NaCl)).
FLAG
Rabbit anti-FLAG (1:2000, Sigma, Anti-Flag polyclonal,
F7425) and anti-rabbit-HRP (1:2000, Promega, W401B)
were used in Blotto-buffer.
His10
Mouse-anti-Penta-His (1:2000, Qiagen, Penta-His, No.
34660) in 1 × TBS, 5% bovine serum albumin (BSA,
Fraction V; Carl ROTH) and anti-mouse-HRP (1:2000,
Promega, W402B1) in 1 × TBS, 10 % (w/v) skim milk
powder were used.
StrepII
Strep-Tactin-HRP conjugate (IBA, Strep-Tactin-HRP con-
jugate, No. 2-1502-001) 1:100 in 1 × PBS (4 mM KH2PO4;
16 mM Na2HPO4; 115 mM NaCl) with 0.1% (w/v)
Tween20 was used.
HA
Rabbit anti-HA (1:500, Sigma, H6908) in TBS, 0.05% (w/v)
Tween20, 5% (w/v) skim milk powder and anti-rabbit-HRP
(1:2000, Promega, W401B) in Blotto-buffer were used.
cMyc
Rabbit anti-Myc (1:2000, Abcan, ab9106) in TBS, 0.05%
(w/v) Tween20, 5% (w/v) skim milk powder and anti-
rabbit-HRP (1:2000, Promega, W401B) in Blotto-buffer
were used.Chemiluminescence signals were detected after addition
of the HRP-substrate Ace Glow (Peqlab, Erlangen,
Germany) using a Fusion™ imaging system (Peqlab).
Determination of luciferase half-life
To determine the half-life of the output of the luciferase
reporter system, B. subtilis harboring the Pxyl-luxABCDE
reporter construct was grown in CSE medium in the
presence of 0.15% (w/v) xylose under the conditions
described for luciferase assays with constitutive promoters.
When luciferase activities reached approximately 105 RLU/
OD600 (early exponential phase), further protein synthesis
was stopped by the addition of 500 μg ml-1 tetracycline,
and luminescence and OD600 were monitored every 5 min
for 1 h. The half-life of the luminescence output was
determined from a fit of the data from eight replicate
assays with an exponential decay function (Additional
file 3: Figure S3).
Data analysis of luciferase assays
For each individual sample, the optical density (OD600)
and luminescence values (RLU) were background-corrected
by subtracting the respective values measured for wells
containing 100 μl of the corresponding medium. Only
for the measurements of the constitutive promoters, in
which wells were inoculated with cells right from the
start of the experiment, the OD600 of pure medium was
initially higher than the OD600 of culture-filled wells, such
that the average values of culture-filled wells at t = 0 h
were used as blank for OD600. In order to compensate
for sample-to-sample variations in the growth lag of
individual cultures, we aligned all individual measure-
ments of the constitutive promoters on the time-axis,
such that OD600 = 0.1 was shifted to t = 0 h. Subsequently
RLU/OD600 values were calculated for individual measure-
ments and for each condition both mean and standard
deviation of RLU/OD600 values were determined from at
least three biological replicates.
Mathematical model for promoter activity
To get an estimate for the time-dependence of the
promoter activity that results in a given luciferase acti-
vity, we set up a simple mathematical model for the
expression of the Lux-system (Figure 6). For simplicity,
the model assumes that one of the Lux proteins is rate-
limiting for light production, such that the lumines-
cence is proportional to this protein species. The
corresponding differential equations for the concentra-
tion of luxABCDE mRNA, m(t), and the rate-limiting Lux
protein, p(t), read
d
dt
m tð Þ ¼ α tð Þ− log 2ð Þ
τm
m tð Þ ð1Þ
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d
dt
p tð Þ ¼ βm tð Þ− log 2ð Þ
τp
p tð Þ; ð2Þ
where α(t) is the time-dependent apparent transcription
rate, β the translation rate and τm and τp the mRNA and
protein half-lives, respectively. Although mRNA and
protein stability might also depend on cell physiology,
time depended changes in these parameters were ignored
to avoid further unknown parameters. Likewise, we did not
model the kinetics of inducer uptake/signal transduction
explicitly, but subsumed these processes in the kinetics
of the time-dependent apparent transcription rate. For
simplicity, the translation rate was directly expressed in
units of RLU/mRNA/min, such that p(t) has units of RLU.
The model in Eqs. (1) and (2) was solved analytically for
p(t), and then fitted to the experimental luminescence
trajectories. To this end, all parameters except α(t) were
fixed to the following values: τp = 4.2 min (experimentally
determined in Additional file 3: Figure S3), β = 104 RLU/
mRNA/min (arbitrary, but adjusted to meet typical tran-
scription rates), τm = 3, 5 and 10 min (typical values for
bacterial mRNA half-lives [63]). Then α(t) was discretized
into N intervals of constant transcription rate αi (i = 1,…N)
(the length of the intervals was adjusted to Δt = 10 min
as in the luciferase assay). Finally, the αi were estimated
by fitting p(t) to the luminescence trajectories using a
trust-region reflective Newton method for least-squares
minimization (MATLAB, The MathWorks, Inc.).
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